In addition to PTX3 protein has been reported to act as an anti-angiogenic factor in multiplemyeloma and to exhibit cytotoxic effects against multiple myeloma cells by impairing signaling between plasma cells bone marrow-derived plasma cells and endothelial cells (Basile et al., 2013). Here, PTX3 is linked to plasma cell myeloma.